Medvedeva, Y
Ovarian hyperstimulation syndrome: A review for emergency clinicians
The mechanism of action involves several physiological processes: Enhanced insulin secretion : They stimulate glucose-dependent insulin release from pancreatic beta cells, which helps lower blood glucose levels without causing hypoglycaemia when glucose levels are normal Suppressed glucagon secretion : They reduce inappropriate glucagon release from pancreatic alpha cells, further improving glycaemic control Delayed gastric emptying : They slow the rate at which food leaves the stomach, promoting satiety and reducing postprandial glucose excursions
Glasner discusses who might benefit from these medications, important limitations of the current research, and why GLP-1s should be viewed as a potential toolnot a curewithin a broader, evidence-based approach to addiction care
For patients whose primary goal is direct visceral fat reduction with the strongest clinical evidence base, we typically use Tesamorelin instead, and the comparison is detailed in our complete guide to Tesamorelin peptide, what it is, how it works, and why visceral fat searches are skyrocketing
They may also contribute to inflammation, which can irritate the digestive tract, she adds